You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

targeted protein fortification

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prematurity; Extreme, Failure to Thrive in Newborn, Growth Retardation Trial in New York (Similac Human Milk Fortifier

Recruiting
  • Prematurity; Extreme
  • +4 more
  • Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid
  • +8 more
  • New York, New York
    Columbia University Medical Center/ New York - Presbyterian
Sep 16, 2022

Post-Discharge Growth and Development of Infants Who Received

Active, not recruiting
  • Premature Infants
    • Houston, Texas
      Baylor College of Medicine / Texas Children's Hospital
    Oct 6, 2022

    Growth Failure Trial in Calgary (Adjustable Human Milk Fortification, Targeted Human Milk Fortification)

    Not yet recruiting
    • Growth Failure
    • Adjustable Human Milk Fortification
    • Targeted Human Milk Fortification
    • Calgary, Alberta, Canada
      Foothills Medical Centre
    Nov 4, 2022

    Very Low Birth Weight Infant, Growth Failure, Donor Breast Milk Trial in Singapore (Protein supplementation, Analysis with Miris

    Not yet recruiting
    • Very Low Birth Weight Infant
    • +2 more
    • Protein supplementation
    • Analysis with Miris Human Milk Analyzer
    • Singapore, Singapore
      KK Women's and Children's Hospital
    Feb 24, 2021

    Premature Birth, Breastmilk Collection, Postnatal Growth Restriction Trial in Loma Linda (Targeted Fortification, Enfamil Liquid

    Recruiting
    • Premature Birth
    • +2 more
    • Targeted Fortification
    • Enfamil Liquid Human Milk Fortifier
    • Loma Linda, California
      Loma Linda University
    Aug 23, 2022

    BPD - Bronchopulmonary Dysplasia, NEC - Necrotizing Enterocolitis, Weight Gain Trial in Warsaw, Warszawa (Tailored enteral

    Recruiting
    • BPD - Bronchopulmonary Dysplasia
    • +4 more
    • Tailored enteral nutrition
    • Warsaw, Poland
    • +1 more
    Dec 30, 2021

    Human Milk, Neonate, Breast Milk Trial in Cleveland (Targeted Fortification, The Miris Human Milk Analyzer)

    Terminated
    • Human Milk
    • +2 more
    • Targeted Fortification
    • The Miris Human Milk Analyzer
    • Cleveland, Ohio
      MetroHealth Medical Center
    Jun 23, 2021

    Gynecologic Cancer Trial (Experimental product - Fortifit® Powder, Standard of care)

    Not yet recruiting
    • Gynecologic Cancer
    • Experimental product - Fortifit® Powder
    • Standard of care
    • (no location specified)
    Oct 14, 2023

    Sarcopenia, Frailty, Malnutrition; Protein Trial in Zurich, Basel (Protein Supplement, Protein-free Supplement, Active Exercise)

    Recruiting
    • Sarcopenia
    • +3 more
    • Protein Supplement
    • +3 more
    • Zurich, ZH, Switzerland
    • +1 more
    Apr 19, 2022

    Psoriatic Arthritis Trial in Beijing (68Ga-FAPI)

    Recruiting
    • Psoriatic Arthritis
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Jan 7, 2023

    Coronary Heart Disease, Low Protein Intake, Sarcopenia Trial in Newcastle Upon Tyne (Protein education, Standard education)

    Recruiting
    • Coronary Heart Disease
    • +2 more
    • Protein education
    • Standard education
    • Newcastle Upon Tyne, United Kingdom
      Newcastle upon Tyne Hospitals NHS Trust
    Sep 1, 2022

    Small for Gestational Age at Delivery, Gestational Weight Gain, Stillbirth Trial in Addis Ababa (Targeted BEP based on baseline

    Recruiting
    • Small for Gestational Age at Delivery
    • +7 more
    • Targeted BEP based on baseline nutritional status
    • +2 more
    • Addis Ababa, Ethiopia
      Addis Continental Institute of Public Health (ACIPH)
    Nov 5, 2023

    Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
    • Edegem, Belgium
      Antwerp University Hospital
    Jul 19, 2023

    Preterm, Very Low Birth Weight Infant, Feeding, Breast Trial in Madrid (Protein supplementation based on plasma urea

    Recruiting
    • Preterm
    • +3 more
    • Protein supplementation based on plasma urea concentration every other week or human milk analysis on experiment
    • Madrid, Spain
      University Hospital La Paz
    Jul 19, 2021

    B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)

    Recruiting
    • B-cell Malignancy, Low-grade
    • +4 more
    • Beijing, Beijing, China
    • +8 more
    Jul 20, 2022

    Ischemic Stroke, Acute, Ischemia-reperfusion Injury, Cerebral Edema Trial in Dongguan, Guangzhou (enzyme-linked immunosorbent

    Recruiting
    • Ischemic Stroke, Acute
    • +2 more
    • enzyme-linked immunosorbent assay(ELISA)
    • Dongguan, Guangdong, China
    • +1 more
    Oct 15, 2022

    18F-FAPI PET/CT Examination, Renal Puncture Biopsy Trial ([18F]AlF-NOTA-FAPI-04 PET/CT examination, Renal puncture biopsy)

    Not yet recruiting
    • 18F-FAPI PET/CT Examination
    • Renal Puncture Biopsy
    • [18F]AlF-NOTA-FAPI-04 PET/CT examination
    • Renal puncture biopsy
    • (no location specified)
    Mar 1, 2023

    HER-2 Gene Amplification, HER2-positive Gastric Cancer, HER2-positive Breast Cancer Trial in United States (chimeric antigen

    Recruiting
    • HER-2 Gene Amplification
    • +4 more
    • chimeric antigen receptor (CAR) T cell therapy
    • Duarte, California
    • +6 more
    Aug 10, 2022

    Multiple Myeloma Trial in New York (Infusion of MCARH109 T cells)

    Active, not recruiting
    • Multiple Myeloma
    • Infusion of MCARH109 T cells
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 5, 2022

    Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory

    Active, not recruiting
    Has Results
    • Castration Levels of Testosterone
    • +9 more
    • Recombinant EphB4-HSA Fusion Protein
    • Los Angeles, California
    • +2 more
    Apr 4, 2022

    Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8, Stage I Intrahepatic

    Not yet recruiting
    • Resectable Intrahepatic Cholangiocarcinoma
    • +4 more
    • Atlanta, Georgia
    • +2 more
    Aug 19, 2022

    Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)

    Not yet recruiting
    • Iron Deficiency Anemia
    • Iron-fortified cookies
    • +3 more
    • (no location specified)
    Aug 30, 2023

    Muscle Protein Synthesis, Sarcopenia Trial in Maastricht (Fortified plant-based protein blend, Plant-based protein blend, Whey

    Not yet recruiting
    • Muscle Protein Synthesis
    • Sarcopenia
    • Fortified plant-based protein blend
    • +2 more
    • Maastricht, Limburg, Netherlands
      Maastricht University Medical Center+
    Feb 1, 2023

    Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)

    Recruiting
    • Advanced Unresectable or Metastatic Solid Malignancy
    • Birmingham, Alabama
    • +50 more
    Aug 10, 2022

    Dietary Intake, Health and Micronutrient Status in Haiti

    Terminated
    • Micronutrient Deficiency
    • +3 more
    • No intervention (descriptive survey only)
    • Pétion-Ville, Haiti
      Partners of the Americas
    Jan 20, 2023